Form 8-K - Current report:
SEC Accession No. 0001493152-25-008282
Filing Date
2025-02-26
Accepted
2025-02-26 08:45:25
Documents
16
Period of Report
2025-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47634
2 ex3-7ii.htm EX-3.7II 201539
3 ex99-1.htm EX-99.1 11434
4 ex99-1_001.jpg GRAPHIC 7914
  Complete submission text file 0001493152-25-008282.txt   496298

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aim-20250224.xsd EX-101.SCH 3015
6 XBRL LABEL FILE aim-20250224_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE aim-20250224_pre.xml EX-101.PRE 24166
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3684
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 25666311
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)